- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
Managing patients with diabetes during COVID-19
How can physicians help patients control their diabetes in the COVID-19 era?
It has never been more challenging to help patients manage chronic conditions, most especially type 2 diabetes.
More than 34 million Americans have diabetes, according to the CDC, and the vast majority of them have type 2. In normal times, managing diabetes is a challenge for physicians, as it requires a strong physician-patient relationship and dedication from patients to adhere to their treatment plans.
Managing this condition has been flipped on its head by the COVID-19 pandemic. As patients with diabetes are now dealing with more remote care and increased stress from the toll the pandemic.
So how can physicians help their patients control their diabetes in the COVID-19 era?
To discuss this important topic, my guest today is Marie E. McDonnell, M.D., an endocrinologist and director of the Brigham Diabetes Program at Brigham and Women’s hospital in Boston, and a lecturer on medicine at Harvard Medical School.
This is part Ione of a two-part conversation with Dr. McDonnell.
